ArticleEClinicalMedicine2023

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial.

I-SPY COVID ConsortiumPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.